logo
搜索
菜单

的搜索结果

当前416/655页
排序: 今日浏览数
9.11: Antihypertensive Drugs: Direct Renin Inhibitors 01:25 min
9.11: Antihypertensive Drugs: Direct Renin Inhibitors
9.9: Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors 01:30 min
9.9: Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
9.8: Antihypertensive Drugs: Action of Calcium Channel Blockers 01:18 min
9.8: Antihypertensive Drugs: Action of Calcium Channel Blockers
9.7: Antihypertensive Drugs: Types of β-Blockers 01:28 min
9.7: Antihypertensive Drugs: Types of β-Blockers
9.6: Antihypertensive Drugs: Action of β1 Blockers 01:17 min
9.6: Antihypertensive Drugs: Action of β1 Blockers
9.5: Antihypertensive Drugs: Potassium-Sparing Diuretics 01:28 min
9.5: Antihypertensive Drugs: Potassium-Sparing Diuretics
9.3: Antihypertensive Drugs: Action of Diuretics 01:16 min
9.3: Antihypertensive Drugs: Action of Diuretics
10.15: Controlled-Current Coulometry: Overview 01:27 min
10.15: Controlled-Current Coulometry: Overview
11.8: Patterns of Fever 01:26 min
11.8: Patterns of Fever
11.7: Types of Fever 01:25 min
11.7: Types of Fever
6.16: Drugs Affecting Neurotransmitter Synthesis 01:29 min
6.16: Drugs Affecting Neurotransmitter Synthesis
3.29: Prodrugs 01:30 min
3.29: Prodrugs
3.11: Physiological Barriers 01:25 min
3.11: Physiological Barriers
3.8: First Pass Effect 01:12 min
3.8: First Pass Effect
1.13: Prescription, Nonprescription and Orphan Drugs 01:02 min
1.13: Prescription, Nonprescription and Orphan Drugs
1.9: Routes of Drug Administration: Overview 01:22 min
1.9: Routes of Drug Administration: Overview
1.2: Preclinical Development: Overview 01:28 min
1.2: Preclinical Development: Overview
5.2: Complexometric Titration: Ligands 00:43 min
5.2: Complexometric Titration: Ligands
16.14: Resting Potential Decay 01:15 min
16.14: Resting Potential Decay
16.13: Resting Membrane Potential 01:24 min
16.13: Resting Membrane Potential
返回顶部